Sei Investments Co. Takes $1.21 Million Position in AngioDynamics, Inc. (NASDAQ:ANGO)

Sei Investments Co. bought a new stake in AngioDynamics, Inc. (NASDAQ:ANGO) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 44,658 shares of the medical instruments supplier’s stock, valued at approximately $1,212,000.

Several other hedge funds have also recently made changes to their positions in ANGO. Altshuler Shaham Ltd bought a new position in AngioDynamics during the first quarter valued at about $43,000. Captrust Financial Advisors grew its position in AngioDynamics by 2,340.0% during the first quarter. Captrust Financial Advisors now owns 1,830 shares of the medical instruments supplier’s stock valued at $43,000 after buying an additional 1,755 shares during the period. Ensign Peak Advisors Inc grew its position in AngioDynamics by 226.3% during the first quarter. Ensign Peak Advisors Inc now owns 12,400 shares of the medical instruments supplier’s stock valued at $290,000 after buying an additional 8,600 shares during the period. Citigroup Inc. grew its position in AngioDynamics by 77.0% during the first quarter. Citigroup Inc. now owns 17,135 shares of the medical instruments supplier’s stock valued at $401,000 after buying an additional 7,456 shares during the period. Finally, Trexquant Investment LP grew its position in AngioDynamics by 37.6% during the first quarter. Trexquant Investment LP now owns 24,373 shares of the medical instruments supplier’s stock valued at $570,000 after buying an additional 6,666 shares during the period. Institutional investors own 96.45% of the company’s stock.

Shares of NASDAQ:ANGO opened at $24.08 on Tuesday. The company has a 50-day moving average price of $27.08 and a two-hundred day moving average price of $25.17. The company has a quick ratio of 1.60, a current ratio of 2.45 and a debt-to-equity ratio of 0.05. AngioDynamics, Inc. has a twelve month low of $9.47 and a twelve month high of $30.25. The firm has a market capitalization of $925.73 million, a PE ratio of -29.37 and a beta of 0.83.

ANGO has been the subject of several research reports. Raymond James increased their price target on shares of AngioDynamics from $27.00 to $32.00 and gave the company a “strong-buy” rating in a research report on Friday, July 9th. Oppenheimer began coverage on shares of AngioDynamics in a research report on Friday, August 20th. They set a “market perform” rating for the company. TheStreet upgraded shares of AngioDynamics from a “d+” rating to a “c” rating in a research report on Tuesday, July 13th. Finally, Canaccord Genuity increased their target price on shares of AngioDynamics from $24.00 to $28.00 and gave the stock a “hold” rating in a research report on Wednesday, July 14th. Three investment analysts have rated the stock with a hold rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and an average target price of $27.33.

AngioDynamics Company Profile

AngioDynamics, Inc is a medical device company, which engages in the development, manufacture, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. It offers ablation systems, fluid management systems, vascular access, angiographic, drainage. thrombolytic, and venous products.

Featured Article: How to Invest in Growth Stocks

Want to see what other hedge funds are holding ANGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AngioDynamics, Inc. (NASDAQ:ANGO).

Institutional Ownership by Quarter for AngioDynamics (NASDAQ:ANGO)

Receive News & Ratings for AngioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AngioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.